Michael Miles, M.D., Ph.D.
Massey Cancer Center research program membership
Cancer Molecular Genetics
Department of Pharmacology and Toxicology,
School of Medicine
MD, Northwestern University (1983)
PhD, Northwestern University (1982)
Awards and honors
Research Scientist Development Award, 1999, National Institute on Alcohol Abuse and Alcoholism
Dr. Miles studies genetic and genomic mechanisms of addiction to nicotine and alcohol. Addiction to these drugs are important risk factors for cancer. Ongoing studies have identified gene networks that influence specific ethanol behaviors. 'Hub genes' identified in these networks have also been identified as risk factors for alcoholism in human genetic studies and potential future therapeutic targets for alcohol use disorders by use of selective small molecule inhibitors in rodent studies. Gene targeted mouse models are being used for more extensive characterization of the mechanisms linking these candidate genes to molecular events leading to the transition to alcoholism or nicotine dependence. Additionally, our recent studies on one candidate gene involved in behavioral responses to alcohol also show this gene to be a risk factor for chemotherapy-induced neuropathy, further highlighting the connection between drug abuse and cancer research.
Disease focus of research
Respiratory - Other
Alcohol, nicotine, gene networks, neuropathy, chemotherapy
Published research (during tenure as a Massey Cancer Center member)
Search In PubMed